Thermoresponsive carboplatin-releasing prodrugs DOI Creative Commons

Aemilia D. McAdam,

Lucinda K. Batchelor,

Jan Romano-deGea

и другие.

Journal of Inorganic Biochemistry, Год журнала: 2024, Номер 254, С. 112505 - 112505

Опубликована: Фев. 15, 2024

Platinum-based anticancer drugs, while potent, are associated with numerous and severe side effects. Hyperthermia therapy is an effective adjuvant in treatment, however, clinically used platinum drugs have not been optimised for combination hyperthermia. The derivatisation of existing appropriately chosen thermoresponsive moieties results being activated only at the heated site. Perfluorinated chains varying lengths were installed on carboplatin, a approved drug, leading to successful synthesis series mono- di- substituted platinum(IV) carboplatin prodrugs. Some these complexes display relevant thermosensitivity ovarian cancer cell lines, i.e., inactive 37 °C having comparable activity under mild hyperthermia (42 °C). Nuclear magnetic resonance spectroscopy mass spectrometry indicated that likely active platinum(II) agent upon reduction cyclic voltammetry revealed length fluorinated alkyl chain has strong influence rate formation, regulating subsequent cytotoxicity.

Язык: Английский

Advances in technical strategies for monitoring the reduction of platinum(iv) complexes DOI Creative Commons
Shu Chen, Qiyuan Zhou,

Ka-Yan Ng

и другие.

Inorganic Chemistry Frontiers, Год журнала: 2024, Номер 11(11), С. 3085 - 3118

Опубликована: Янв. 1, 2024

The reduction of Pt( iv ) complexes can be monitored by various analytical techniques. These techniques hold significant promise in elucidating the mechanisms prodrug activation, aiding rational design novel prodrugs.

Язык: Английский

Процитировано

4

Facile synthesis of a hydrazone-based zinc(ii) complex for ferroptosis-augmented sonodynamic therapy DOI Creative Commons
Dan Li,

Minghui Fan,

Haobing Wang

и другие.

Chemical Science, Год журнала: 2024, Номер 15(26), С. 10027 - 10035

Опубликована: Янв. 1, 2024

This work reports a facilely synthesized zinc( ii ) complex based on hydrazone ligand for ferroptosis-augmented sonodynamic therapy.

Язык: Английский

Процитировано

4

Mitochondrion-specific organometallic sonosensitizer boosts synergistic sonodynamic therapy for augmented ferroptosis to trigger systemic immunity DOI
Ziying Wang, Yaohui He,

Yibo An

и другие.

Nano Today, Год журнала: 2024, Номер 57, С. 102369 - 102369

Опубликована: Июнь 16, 2024

Язык: Английский

Процитировано

4

Recent advances in the development of metallodrugs for cancer chemoimmunotherapy DOI

Fangmian Wei,

Jinzhe Liang, Xing‐Can Shen

и другие.

Coordination Chemistry Reviews, Год журнала: 2024, Номер 526, С. 216319 - 216319

Опубликована: Ноя. 28, 2024

Язык: Английский

Процитировано

4

Thermoresponsive carboplatin-releasing prodrugs DOI Creative Commons

Aemilia D. McAdam,

Lucinda K. Batchelor,

Jan Romano-deGea

и другие.

Journal of Inorganic Biochemistry, Год журнала: 2024, Номер 254, С. 112505 - 112505

Опубликована: Фев. 15, 2024

Platinum-based anticancer drugs, while potent, are associated with numerous and severe side effects. Hyperthermia therapy is an effective adjuvant in treatment, however, clinically used platinum drugs have not been optimised for combination hyperthermia. The derivatisation of existing appropriately chosen thermoresponsive moieties results being activated only at the heated site. Perfluorinated chains varying lengths were installed on carboplatin, a approved drug, leading to successful synthesis series mono- di- substituted platinum(IV) carboplatin prodrugs. Some these complexes display relevant thermosensitivity ovarian cancer cell lines, i.e., inactive 37 °C having comparable activity under mild hyperthermia (42 °C). Nuclear magnetic resonance spectroscopy mass spectrometry indicated that likely active platinum(II) agent upon reduction cyclic voltammetry revealed length fluorinated alkyl chain has strong influence rate formation, regulating subsequent cytotoxicity.

Язык: Английский

Процитировано

3